• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情期间婴儿血管瘤的管理

Management of infantile hemangiomas during the COVID pandemic.

作者信息

Frieden Ilona J, Püttgen Katherine B, Drolet Beth A, Garzon Maria C, Chamlin Sarah L, Pope Elena, Mancini Anthony J, Lauren Christine T, Mathes Erin F, Siegel Dawn H, Gupta Deepti, Haggstrom Anita N, Tollefson Megha M, Baselga Eulalia, Morel Kimberly D, Shah Sonal D, Holland Kristen E, Adams Denise M, Horii Kimberly A, Newell Brandon D, Powell Julie, McCuaig Catherine C, Nopper Amy J, Metry Denise W, Maguiness Sheilagh

机构信息

University of California San Francisco, San Francisco, California, USA.

Intermountain Healthcare, Salt Lake City, Utah, USA.

出版信息

Pediatr Dermatol. 2020 May;37(3):412-418. doi: 10.1111/pde.14196. Epub 2020 May 16.

DOI:10.1111/pde.14196
PMID:32298480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7262142/
Abstract

The COVID-19 pandemic has caused significant shifts in patient care including a steep decline in ambulatory visits and a marked increase in the use of telemedicine. Infantile hemangiomas (IH) can require urgent evaluation and risk stratification to determine which infants need treatment and which can be managed with continued observation. For those requiring treatment, prompt initiation decreases morbidity and improves long-term outcomes. The Hemangioma Investigator Group has created consensus recommendations for management of IH via telemedicine. FDA/EMA-approved monitoring guidelines, clinical practice guidelines, and relevant, up-to-date publications regarding initiation and monitoring of beta-blocker therapy were used to inform the recommendations. Clinical decision-making guidelines about when telehealth is an appropriate alternative to in-office visits, including medication initiation, dosage changes, and ongoing evaluation, are included. The importance of communication with caregivers in the context of telemedicine is discussed, and online resources for both hemangioma education and propranolol therapy are provided.

摘要

新冠疫情导致了患者护理方面的重大转变,包括门诊就诊量急剧下降以及远程医疗的使用显著增加。婴儿血管瘤(IH)可能需要紧急评估和风险分层,以确定哪些婴儿需要治疗,哪些可以通过持续观察来管理。对于那些需要治疗的婴儿,及时开始治疗可降低发病率并改善长期预后。血管瘤研究小组制定了通过远程医疗管理婴儿血管瘤的共识建议。美国食品药品监督管理局/欧洲药品管理局批准的监测指南、临床实践指南以及有关β受体阻滞剂治疗的启动和监测的相关最新出版物为这些建议提供了依据。其中包括关于远程医疗何时是门诊就诊合适替代方式的临床决策指南,涵盖药物起始、剂量调整和持续评估等方面。讨论了在远程医疗背景下与护理人员沟通的重要性,并提供了有关血管瘤教育和普萘洛尔治疗的在线资源。

相似文献

1
Management of infantile hemangiomas during the COVID pandemic.新冠疫情期间婴儿血管瘤的管理
Pediatr Dermatol. 2020 May;37(3):412-418. doi: 10.1111/pde.14196. Epub 2020 May 16.
2
Optimizing your telemedicine visit during the COVID-19 pandemic: Practice guidelines for patients with head and neck cancer.优化 COVID-19 大流行期间的远程医疗访问:头颈部癌症患者的实践指南。
Head Neck. 2020 Jun;42(6):1317-1321. doi: 10.1002/hed.26197. Epub 2020 Apr 28.
3
Exercising in Isolation? The Role of Telehealth in Exercise Oncology During the COVID-19 Pandemic and Beyond.独自锻炼?远程医疗在新冠疫情期间及之后运动肿瘤学中的作用。
Phys Ther. 2020 Sep 28;100(10):1713-1716. doi: 10.1093/ptj/pzaa141.
4
Telemedicine and Virtual Health Care during Coronavirus Disease Pandemic.冠状病毒病大流行期间的远程医疗与虚拟医疗保健
JNMA J Nepal Med Assoc. 2020 Aug 31;58(228):547-549. doi: 10.31729/jnma.5204.
5
Evaluation and treatment of thoracic outlet syndrome during the global pandemic due to SARS-CoV-2 and COVID-19.评估和治疗由于 SARS-CoV-2 和 COVID-19 引起的全球大流行期间的胸廓出口综合征。
J Vasc Surg. 2020 Sep;72(3):790-798. doi: 10.1016/j.jvs.2020.05.048. Epub 2020 Jun 1.
6
Telehealth: Opportunities in geriatric patient care during COVID-19.远程医疗:COVID-19 期间老年患者护理中的机遇
Geriatr Nurs. 2020 Sep-Oct;41(5):657-658. doi: 10.1016/j.gerinurse.2020.08.013. Epub 2020 Aug 31.
7
Considerations for management of longitudinal melanonychia during the coronavirus disease 2019 (COVID-19) pandemic: An international perspective.2019冠状病毒病(COVID-19)大流行期间纵向黑甲管理的考量:国际视角
J Am Acad Dermatol. 2020 Aug;83(2):e159-e161. doi: 10.1016/j.jaad.2020.05.028. Epub 2020 May 13.
8
Development of a telehealth geriatric assessment model in response to the COVID-19 pandemic.为应对新冠疫情而开发的远程医疗老年评估模型。
J Geriatr Oncol. 2020 Jun;11(5):761-763. doi: 10.1016/j.jgo.2020.04.007. Epub 2020 Apr 17.
9
Practice change amidst the COVID-19 pandemic: Harnessing the momentum for expanding telehealth in transplant.2019冠状病毒病大流行期间的实践变革:利用这一势头扩大移植领域的远程医疗服务
Clin Transplant. 2020 Jul;34(7):e13897. doi: 10.1111/ctr.13897. Epub 2020 May 22.
10
Incorporating telemedicine as part of COVID-19 outbreak response systems.将远程医疗纳入 COVID-19 疫情应对系统。
Am J Manag Care. 2020 Apr;26(4):147-148. doi: 10.37765/ajmc.2020.42784.

引用本文的文献

1
Knowledge, attitudes, and practices on hemangioma among parents of infantile hemangioma patients in South China.中国南方婴幼儿血管瘤患者家长对血管瘤的认知、态度及行为
Sci Rep. 2025 May 2;15(1):15350. doi: 10.1038/s41598-025-00228-7.
2
Pediatric vascular anomalies in Austria. Where are we at? A survey among primary care pediatricians.奥地利的儿科血管异常。我们目前的情况如何?一项针对基层儿科医生的调查。
Front Pediatr. 2023 Aug 17;11:1216460. doi: 10.3389/fped.2023.1216460. eCollection 2023.
3
Consensus Guidelines for Teledermatology: Scoping Review.远程皮肤病学共识指南:范围综述
JMIR Dermatol. 2023 May 15;6:e46121. doi: 10.2196/46121.
4
Infantile Hemangioma: A Common Lesion in a Vulnerable Population.婴儿血管瘤:弱势群体中的常见病变。
Int J Environ Res Public Health. 2023 Apr 20;20(8):5585. doi: 10.3390/ijerph20085585.
5
Analysis of Therapeutic Decisions for Infantile Hemangiomas: A Prospective Study Comparing the Hemangioma Severity Scale with the Infantile Hemangioma Referral Score.婴儿血管瘤治疗决策分析:一项比较血管瘤严重程度量表与婴儿血管瘤转诊评分的前瞻性研究
Children (Basel). 2022 Nov 28;9(12):1851. doi: 10.3390/children9121851.
6
Paediatrics: how to manage infantile haemangioma.儿科学:如何处理婴幼儿血管瘤
Drugs Context. 2021 Apr 6;10. doi: 10.7573/dic.2020-12-6. eCollection 2021.
7
Morphological, genetic and clinical correlations in infantile hemangiomas and their mimics.婴幼儿血管瘤及其类似物的形态学、遗传学和临床相关性。
Rom J Morphol Embryol. 2020 Jul-Sep;61(3):687-695. doi: 10.47162/RJME.61.3.07.
8
Clinical Features of Segmental Infantile Hemangioma: A Prospective Study.节段性婴儿血管瘤的临床特征:一项前瞻性研究。
Ther Clin Risk Manag. 2021 Jan 27;17:119-125. doi: 10.2147/TCRM.S291059. eCollection 2021.
9
Covid-19 pandemic and the skin.新冠疫情与皮肤。
Int J Dermatol. 2020 Nov;59(11):1312-1319. doi: 10.1111/ijd.15189. Epub 2020 Sep 21.
10
At-home dose escalation of propranolol for infantile hemangiomas during the COVID-19 pandemic.在新冠疫情期间,在家中递增普萘洛尔剂量治疗婴儿血管瘤。
Dermatol Ther. 2020 Nov;33(6):e13977. doi: 10.1111/dth.13977. Epub 2020 Jul 16.

本文引用的文献

1
Limited utility of repeated vital sign monitoring during initiation of oral propranolol for complicated infantile hemangioma.在开始口服普萘洛尔治疗复杂婴幼儿血管瘤期间,重复监测生命体征的效果有限。
J Am Acad Dermatol. 2021 Aug;85(2):345-352. doi: 10.1016/j.jaad.2020.04.013. Epub 2020 Apr 11.
2
Modalities of use of oral propranolol in proliferative infantile haemangiomas: an international survey among practitioners.口服普萘洛尔治疗增殖期婴幼儿血管瘤的使用方式:一项针对从业者的国际调查
Br J Dermatol. 2020 Sep;183(3):573-575. doi: 10.1111/bjd.19047. Epub 2020 Apr 27.
3
Epidemiology of COVID-19 Among Children in China.中国儿童 COVID-19 流行病学。
Pediatrics. 2020 Jun;145(6). doi: 10.1542/peds.2020-0702. Epub 2020 Mar 16.
4
The Infantile Hemangioma Referral Score: A Validated Tool for Physicians.婴幼儿血管瘤转诊评分:一种经验证的医生用工具。
Pediatrics. 2020 Apr;145(4). doi: 10.1542/peds.2019-1628. Epub 2020 Mar 11.
5
Evaluation of a modified outpatient model for using propranolol to treat infantile hemangiomas.一种使用普萘洛尔治疗婴儿血管瘤的改良门诊模式的评估。
Pediatr Dermatol. 2019 Jul;36(4):471-476. doi: 10.1111/pde.13843. Epub 2019 May 23.
6
Systemic timolol exposure following topical application to infantile hemangiomas.局部应用于婴儿血管瘤后全身的噻吗洛尔暴露情况。
J Am Acad Dermatol. 2020 Mar;82(3):733-736. doi: 10.1016/j.jaad.2019.02.029. Epub 2019 Feb 18.
7
Clinical Practice Guideline for the Management of Infantile Hemangiomas.婴幼儿血管瘤管理临床实践指南。
Pediatrics. 2019 Jan;143(1). doi: 10.1542/peds.2018-3475.
8
Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines.口服普萘洛尔治疗增殖性婴儿血管瘤:英国儿科皮肤病学会共识指南。
Br J Dermatol. 2018 Sep;179(3):582-589. doi: 10.1111/bjd.16779.
9
Safety and efficacy of topical timolol treatment of infantile haemangioma: a prospective trial.噻吗洛尔局部治疗婴儿血管瘤的安全性和有效性:一项前瞻性试验。
Br J Dermatol. 2018 Jan;178(1):e51-e52. doi: 10.1111/bjd.15865. Epub 2017 Dec 29.
10
The Role of Topical Timolol in the Treatment of Infantile Hemangiomas: A Systematic Review and Meta-analysis.局部用噻吗洛尔治疗婴儿血管瘤的作用:系统评价和荟萃分析。
Acta Derm Venereol. 2017 Nov 15;97(10):1167-1171. doi: 10.2340/00015555-2681.